Incyte Corporation (INCY): Price and Financial Metrics
Today's Latest Price: $95.08 USD
Jan 27 1:28pm Add INCY to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
INCY Stock Summary INCY has a market capitalization of $21,766,021,385 -- more than approximately 89.86% of US stocks. Of note is the ratio of Incyte Corp's sales and general administrative expense to its total operating expenses; only 9.08% of US stocks have a lower such ratio. For INCY, its debt to operating expenses ratio is greater than that reported by merely 5.57% of US equities we're observing. If you're looking for stocks that are quantitatively similar to Incyte Corp, a group of peers worth examining would be VIR, BNTX, BGNE, SRPT, and NTLA. Visit INCY's SEC page to see the company's official filings. To visit the company's web site, go to www.incyte.com.
INCY Price/Volume Stats
Incyte Corporation (INCY) Company Bio
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics in oncology in the United States and internationally. The company was founded in 1991 and is based in Wilmington, Delaware.
INCY Latest News Stream
All News Types
Loading, please wait...
Latest INCY News From Around the Web
Below are the latest news stories about Incyte Corp that investors may wish to consider to help them evaluate INCY as an investment opportunity.
Incyte's (INCY) application for pipeline candidate, retifanlimab, for adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal (SCAC) gets Priority Review.
Mizuho Securities Stick to Their Hold Rating for Incyte Corp
WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Squamous Cell Carcinoma of the Anal Canal (SCAC)
WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) announced today that it has scheduled its fourth quarter and year-end 2020 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, February 9, 2021. The schedule for the press release and conference call/webcast is as follows: • Q4 & YE 2020 Press Release: February 9, 2021 at 7:00 a.m. ET • Q4 & YE 2020 Conference Call: February 9, 2021 at 8:00 a.m. ET • Domestic Dial-In Number: 877-407-3042 • International Dial-
RBC Capital Stick to Their Hold Rating for Incyte Corp
Read More 'INCY' Stories Here
INCY Price Returns
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!
Page generated in 0.905 seconds.